Table 1a.
Overview of visual and refractive results after implantation with an anterior chamber angle supported phakic intraocular lens
| Nr. eyes [nr. pt] | Follow-up (mo) | MRSE | % within target | UDVA | CDVA | Indices | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| preop | postop | +/- 0.5D | +/- 1.0D | 20/20 (%) | 20/40 (%) | 20/20 (%) | 20/40 (%) | Efficacy | Safety | |||
| Artisan Myopia (Toric), Ophtec | ||||||||||||
| Kohnen, T., 2009[19] | 190 [190] | 24 | -10.38 | -0.23 | 72.7 | 95.7 | 57.8 | 99.4 | 85.7 | 100 | 1.04 | 1.25 |
| Knorz. M.C., 2011[20] | 360 [NR] | 36 | -10.41 | -0.24 | 78.9 | 91.3 | 46.2 | 97.1 | 80.8 | 100 | 0.92 | 1.21 |
| Mastropasqua, L., 2012[21] | 36 [NR] | 12 | NR | NR | 67 | 100 | 56 | 100 | NR | NR | 0.81 | NR |
| Yang, R.B., 2012[22] | 25 [13] | 12 | -12.08 | -0.23 | 84 | 100 | 60 | 100 | 92 | 100 | 1.04 | 1.13 |
| Kermani, O., 2013[23] | 50 [28] | 3 | -9.71 | -0.35 | 84 | NR | 69 | NR | NR | NR | NR | NR |
| Taneri, S., 2014[24] | 15 [15] | 12 | -11.25 | -0.46 | NR | NR | NR | NR | NR | NR | NR | NR |
| Aerts, A.A., 2015[25] | 79 [NR] | 24 | -10.27 | -0.17 | 91 | 95 | 73 | 100 | 85 | NR | 1.00 | 1.11 |
| Gimbel, H.V., 2015[26] | 51 [NR] | 36 | -9.26 | -0.33 | 78.4 | 92.2 | 77.6 | 98 | NR | NR | 0.93 | 1.07 |
| Kohnen, T., 2016[18] | 415 [360] | 60 | -10.41 | -0.34 | 70 | 89.8 | NR | 94.7 | 91.3 | 100 | NR | NR |
| Alio, J.L., 2017[27] | 25 [NR] | 60 | -12.27 | -0.59 | 48 | 76 | 20 | 88 | 68 | NR | 0.81 | 1.14 |
| Al-Qahtani, S., 2018[28] | 36 [21] | 36 | -10.5 | NR | NR | NR | NR | NR | 41.7 | NR | NR | NR |
Mo = Months; MRSE = Manifest refractive spherical equivalent; D = Diopter; UDVA = Uncorrected distance visual acuity; CDVA = Corrected distance visual acuity; NR = Not reported